Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3383096 | Reumatología Clínica | 2012 | 7 Pages |
Abstract
These outcomes confirm that LFN 100Â mg/week offers an adequate and sustained improvement effect on the clinical manifestations of RA, similar to low dose treatment with MTX 10Â mg/every week after 52 weeks of follow up; it may be a good therapeutic option alone or in combination with others anti-rheumatic drugs.
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Jorge Jaimes-Hernández, Claudia Irene Meléndez-Mercado, Angélica Mendoza-Fuentes, Pablo Aranda-Pereira, Gilberto Castañeda-Hernández,